Get the Stockscreener App
463.04
0.99%
-4.64
Pre-market:
463.51
0.47
+0.10%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $463.04, with a volume of 2.76M.
It is down -0.99% in the last 24 hours and up +9.86% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$467.68
Open:
$461.03
24h Volume:
2.76M
Relative Volume:
0.98
Market Cap:
$174.79B
Revenue:
$43.21B
Net Income/Loss:
$6.58B
P/E Ratio:
26.78
EPS:
17.29
Net Cash Flow:
$6.17B
1W Performance:
-3.19%
1M Performance:
+9.86%
6M Performance:
-22.54%
1Y Performance:
-25.53%
1-Day Range:
$451.45
$464.10
1-Week Range:
$451.45
$488.52
52-Week Range:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
463.04 | 176.55B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.09 | 141.18B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
535.54 | 42.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.50 | 32.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.45 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher: New Headwinds Could Delay The Industry's Recovery (NYSE:TMO) - Seeking Alpha
Contract Manufacturing Market Forecast to 2030, with Case Studies of Thermo Fisher Scientific and Flextronics - GlobeNewswire
What makes Thermo Fisher Scientific Inc. stock price move sharplyFree Stock Market Forecast Reports - jammulinksnews.com
Is Thermo Fisher Scientific Inc. stock overvalued or undervaluedStrong return on investment - jammulinksnews.com
Stifel Reaffirms Buy on Thermo Fisher (TMO) Despite Price Target Cut - Insider Monkey
Thermo Fisher 2025 Q2 Earnings Strong Performance as Net Income Grows 4% - AInvest
THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation - Yahoo Finance
Why Thermo Fisher Scientific Inc. stock attracts strong analyst attentionMomentum Based Equity Trading Plans Reviewed - beatles.ru
How does Thermo Fisher Scientific Inc. compare to its industry peersMarket Forecast Insights For 2025 - jammulinksnews.com
Here’s Why Thermo Fisher Scientific (TMO) Traded Down in Q2 - Insider Monkey
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.
Global G-Protein Coupled Receptors Market [2025-2032] - openPR.com
Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific - Yahoo Finance
Drug Abuse Testing Market Forecast and Company Analysis - GlobeNewswire
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance
5 Insightful Analyst Questions From Thermo Fisher’s Q2 Earnings Call - TradingView
Thermo Fisher Margins Feel The Weight Of Tariffs Even As China Trade Pressures Ease In Q2 - insights.citeline.com
Thermo Fisher's Q2 revenue and EPS beat estimates, driven by Life Sciences Solutions growth and strong product launches. - AInvest
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ... - Yahoo Finance
Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450 - MSN
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now - MSN
Thermo Fisher Scientific showcases diagnostics solutions designed to meet evolving global healthcare demands at ADLM 2025 - SelectScience
North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - Yahoo Finance
Thermo Fisher Scientific EVP Pettiti Sells 400 Shares at $479.98/Share. - AInvest
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid market shifts - Investing.com
COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn - openPR.com
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth - MSN
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025 - 01net
Cell Reprogramming Market Future Business Opportunities - openPR.com
How many analysts rate Thermo Fisher Scientific Inc. as a “Buy”Outstanding risk-reward balance - jammulinksnews.com
What is the risk reward ratio of investing in Thermo Fisher Scientific Inc. stockInvest confidently with expert support - jammulinksnews.com
Is Thermo Fisher Scientific Inc. a growth stock or a value stockExponential return rates - jammulinksnews.com
Thermo Fisher Scientific's (TMO) Q2 Outperformance and Revised Price Target: Is Now the Time to Buy? - AInvest
Refurbished Laboratory Equipment Market Top Companies Study - openPR.com
What are the technical indicators suggesting about Thermo Fisher Scientific Inc.Phenomenal capital appreciation - jammulinksnews.com
When is Thermo Fisher Scientific Inc. stock expected to show significant growthDiscover high-impact investment opportunities - jammulinksnews.com
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
Thermo Fisher Scientific Inc. (TMO) Has Finally Got It Together, Says Jim Cramer - MSN
Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480 - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentFree Stock Index Interpretation - PrintWeekIndia
Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference - Yahoo Finance
Fortune 500 Power Moves: Which executives gained and lost power this week, July 19-25, 2025 - Fortune
Thermo Fisher Unit Can’t Undo Executive’s $24 Million Bias Win - Bloomberg Law News
Analyst recommendations: Thermo Fisher Scientific, Intel, Honeywell International, Union Pacific, Gilead Sciences... - MarketScreener
Thermo Fisher Scientific Second Quarter 2025 Earnings: Beats Expectations - simplywall.st
Microplate Readers Market Is Booming So Rapidly 2025-2032 - openPR.com
Thermo Fisher Scientific Increases Accessibility to Research with the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - AZoM
ICP-MS System Market Key Players AnalysisPerkinElmer, Inc., - openPR.com
Stifel lowers Thermo Fisher Scientific stock price target to $583 on mixed outlook - Investing.com Canada
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):